Home › NDC Lookup › RxCUI directory › RxCUI 2679797

Sacubitril 15 MG / valsartan 16 MG Oral Pellet [Entresto] — RxCUI 2679797

RxNorm drug concept · Semantic branded drug
RxCUI 2679797 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2679797
Official nameSacubitril 15 MG / valsartan 16 MG Oral Pellet [Entresto]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEntresto Sprinkle (sacubitril 15 MG / valsartan 16 MG) Oral Pellet; Entresto Sprinkle 15 MG / 16 MG Oral Pellet
FDA products mapped7
Package NDCs mapped10
Reported Medicaid activity (SDUD)657,545 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valsartan and Sacubitril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sacubitril and valsartan works on two fronts at once. One part (sacubitril) helps your body's own protective heart hormones stick around longer, which helps your kidneys get rid of...
  • What exactly is this medication supposed to do for my heart failure?
  • That's a really important question. A few combinations need to be avoided or watched carefully. You should never take this with an ACE inhibitor like lisinopril or enalapril at the...
  • Can I take it with my other medications? I'm also on ibuprofen sometimes for pain.
📖 Read our full Valsartan and Sacubitril guide →

🕸️ Concept Web — How Sacubitril 15 MG / valsartan 16 MG Oral Pellet [... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sacubitril 15 MG / valsartan 16 MG Oral Pellet [Entresto] RxCUI 2679797

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Sacubitril 1656328
    • Valsartan 69749
    • Sacubitril / valsartan 1656339
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Entresto 1656341
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sacubitril / valsartan Oral Pellet 2679792
    • Sacubitril / valsartan Oral Product 1656336
    • Sacubitril / valsartan Pellet Product 2679791
    • Sacubitril / valsartan Oral Pellet [Entresto] 2679796
    • Entresto Oral Product 1656344
    • Entresto Pellet Product 2679795
    • Oral Pellet 317691
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sacubitril 15 MG / valsartan 16 MG Oral Pellet SCD · 2679793
  • Sacubitril 15 MG SCDC · 2679789
  • Valsartan 16 MG SCDC · 2679790
  • Sacubitril / valsartan Oral Pellet SCDF · 2679792
  • Sacubitril / valsartan Oral Product SCDG · 1656336
  • Sacubitril / valsartan Pellet Product SCDG · 2679791

Brand-Name Concepts

  • Sacubitril 15 MG / valsartan 16 MG [Entresto] SBDC · 2679794
  • Sacubitril / valsartan Oral Pellet [Entresto] SBDF · 2679796
  • Entresto Oral Product SBDG · 1656344
  • Entresto Pellet Product SBDG · 2679795
  • Entresto BN · 1656341

📦 FDA Products & Package NDCs

7 products · 10 package NDCs
10 package NDCs map to RxCUI 2679797 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0659-20 60 TABLET, FILM COATED in 1 BOTTLE (0078-0659-20) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-0659-67 180 TABLET, FILM COATED in 1 BOTTLE (0078-0659-67) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-0696-20 60 TABLET, FILM COATED in 1 BOTTLE (0078-0696-20) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-0696-67 180 TABLET, FILM COATED in 1 BOTTLE (0078-0696-67) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-0777-20 60 TABLET, FILM COATED in 1 BOTTLE (0078-0777-20) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-0777-67 180 TABLET, FILM COATED in 1 BOTTLE (0078-0777-67) ENTRESTO Novartis Pharmaceuticals Corporation 2015-07-07
00078-1231-20 60 PELLET in 1 BOTTLE (0078-1231-20) ENTRESTO Novartis Pharmaceuticals Corporation 2024-04-12
00078-1238-20 60 PELLET in 1 BOTTLE (0078-1238-20) ENTRESTO Novartis Pharmaceuticals Corporation 2024-04-12
00078-9659-50 28 TABLET, FILM COATED in 1 BOTTLE (0078-9659-50) ENTRESTO Novartis Pharmaceuticals Corporation 2018-08-23
00078-9777-50 28 TABLET, FILM COATED in 1 BOTTLE (0078-9777-50) ENTRESTO Novartis Pharmaceuticals Corporation 2018-08-23
Observed labelers: Novartis Pharmaceuticals Corporation (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.